BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 33957886)

  • 1. Progesterone levels on the human chorionic gonadotropin trigger day affect the pregnancy rates for embryos transferred at different stages of development in both general and selected IVF/ICSI populations.
    Merviel P; Bouée S; Jacamon AS; Chabaud JJ; Le Martelot MT; Roche S; Rince C; Drapier H; Perrin A; Beauvillard D
    BMC Pregnancy Childbirth; 2021 May; 21(1):363. PubMed ID: 33957886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.
    Huang Y; Wang EY; Du QY; Xiong YJ; Guo XY; Yu YP; Sun YP
    Reprod Biol Endocrinol; 2015 Aug; 13():82. PubMed ID: 26238449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum progesterone level above 0.85 ng/mL and progesterone/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation.
    Tokgoz VY; Tekin AB
    Arch Gynecol Obstet; 2022 Apr; 305(4):1011-1019. PubMed ID: 34716819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law.
    Corti L; Papaleo E; Pagliardini L; Rabellotti E; Molgora M; La Marca A; Vigano P; Candiani M
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):73-7. PubMed ID: 24012449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
    Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
    J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of hCG Triggering Progesterone Levels: A Real-World Retrospective Cohort Study of More Than 8000 IVF/ICSI Cycles.
    De Cesare R; Morenghi E; Cirillo F; Ronchetti C; Canevisio V; Persico P; Baggiani A; Sandri MT; Levi-Setti PE
    Front Endocrinol (Lausanne); 2020; 11():547684. PubMed ID: 33071968
    [No Abstract]   [Full Text] [Related]  

  • 7. Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.
    Merviel P; Menard M; Cabry R; Scheffler F; Lourdel E; Le Martelot MT; Roche S; Chabaud JJ; Copin H; Drapier H; Benkhalifa M; Beauvillard D
    Reprod Sci; 2021 Feb; 28(2):495-509. PubMed ID: 32886340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The individualized choice of embryo transfer timing for patients with elevated serum progesterone level on the HCG day in IVF/ICSI cycles: a prospective randomized clinical study.
    Yang S; Pang T; Li R; Yang R; Zhen X; Chen X; Wang H; Ma C; Liu P; Qiao J
    Gynecol Endocrinol; 2015 May; 31(5):355-8. PubMed ID: 25558791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum oestradiol/progesterone ratio on the day of OPU + 7, but not the day of OPU + 5, affects the rates of live birth in fresh blastocyst embryo transfer cycles.
    Zhao W; Diao H; Chen X; Xu S; Jiang S; Cao H; Zhang C; Zhang Y
    J Ovarian Res; 2023 Jan; 16(1):4. PubMed ID: 36611200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
    J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of progesterone on hCG day-to-basal progesterone ratio on live birth rate in long agonist fresh IVF/ICSI cycles: a 5-year, single-center study of more than 10,000 cycles.
    Hu L; Xiong Y; Wang M; Shi H; Sun Y
    Gynecol Endocrinol; 2021 Aug; 37(8):706-710. PubMed ID: 33438480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The slow growing embryo and premature progesterone elevation: compounding factors for embryo-endometrial asynchrony.
    Healy MW; Yamasaki M; Patounakis G; Richter KS; Devine K; DeCherney AH; Hill MJ
    Hum Reprod; 2017 Feb; 32(2):362-367. PubMed ID: 27986817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S; Polyzos NP; Haentjens P; Smitz J; Camus M; Tournaye H; Blockeel C
    Hum Reprod; 2014 Aug; 29(8):1698-705. PubMed ID: 24939956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
    Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
    Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?
    Azem F; Tal G; Lessing JB; Malcov M; Ben-Yosef D; Almog B; Amit A
    Gynecol Endocrinol; 2008 Jul; 24(7):368-72. PubMed ID: 18645708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse impact of elevated progesterone levels on human chorionic gonadotropin trigger day on blastocyst transfer outcomes in gonadotropin-releasing hormone agonist cycles.
    Kong N; Liu J; Jiang Y; Zhu Y; Zhang C; Yan G; Sun H; Huang C
    Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():107-112. PubMed ID: 35853270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles.
    Vanni VS; Somigliana E; Reschini M; Pagliardini L; Marotta E; Faulisi S; Paffoni A; Vigano' P; Vegetti W; Candiani M; Papaleo E
    PLoS One; 2017; 12(5):e0176482. PubMed ID: 28520729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.